{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:09:45Z","timestamp":1762999785425},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Project of Changzhou","award":["CJ20200057"],"award-info":[{"award-number":["CJ20200057"]}]},{"name":"Qingmiao Talents Cultivation Project of Changzhou Health Commission","award":["CZQM2020089"],"award-info":[{"award-number":["CZQM2020089"]}]},{"name":"the 333 High-level Talents Project of Jiangsu Province","award":["LGY2020032"],"award-info":[{"award-number":["LGY2020032"]}]},{"name":"Project of High-quality Education Resources of Nanjing Medical University","award":["2021H049"],"award-info":[{"award-number":["2021H049"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Omicron variant (B.1.1.529) is a dominant variant worldwide. However, the risk factors for Omicron variant clearance are yet unknown. The present study aimed to investigate the risk factors for early viral clearance of Omicron variant in patients with a history of inactivated vaccine injection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Demographic, clinical, and epidemiological data from 187 patients were collected retrospectively during the Omicron variant wave.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>73\/187 and 114\/187 patients were administered two and three doses of vaccine, respectively. The median duration of SARS-CoV-2 RNA positivity was 9\u00a0days, and the difference between patients with two and three vaccine injections was insignificant (P\u2009=\u20090.722). Fever was the most common symptom (125\/187), and most patients (98.4%) had a fever for\u2009&lt;\u20097\u00a0days. The RNA was undetectable in 65\/187 patients on day 7. Univariable logistic analysis showed that baseline glucose, uric acid, lymphocytes count, platelet count, and CD4<jats:sup>+<\/jats:sup> T lymphocyte count were associated with SARS-CoV-2 RNA-positivity on day 7. Multivariable analysis showed that glucose\u2009\u2265\u20096.1\u00a0mmol\/L and CD4<jats:sup>+<\/jats:sup>T lymphocytes count were independent risk factors for RNA positivity on day 7. 163\/187 patients had an undetectable RNA test on day 14, and uric acid was the only independent risk factor for RNA positivity. Moreover, baseline glucose was negatively correlated with uric acid and CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cell count, while uric acid was positively correlated with CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cell count.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Omicron variant clearance was delayed in breakthrough cases with elevated fasting blood glucose, irrespective of the doses of inactivated vaccine.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-022-01877-0","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T08:09:48Z","timestamp":1663056588000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiujun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guocan","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longgen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"issue":"7","key":"1877_CR1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2119682","volume":"386","author":"RP Bhattacharyya","year":"2022","unstructured":"Bhattacharyya RP, Hanage WP. Challenges in inferring intrinsic severity of the SARS-CoV-2 omicron variant. N Engl J Med. 2022;386(7): e14. https:\/\/doi.org\/10.1056\/NEJMp2119682.","journal-title":"N Engl J Med"},{"issue":"6","key":"1877_CR2","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1002\/jmv.27633","volume":"94","author":"RK Mohapatra","year":"2022","unstructured":"Mohapatra RK, Tiwari R, Sarangi AK, et al. Omicron (B11529) variant of SARS-CoV-2: concerns, challenges, and recent updates. J Med Virol. 2022;94(6):2336\u201342. https:\/\/doi.org\/10.1002\/jmv.27633.","journal-title":"J Med Virol"},{"key":"1877_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.877101","author":"Y Guo","year":"2022","unstructured":"Guo Y, Han J, Zhang Y, et al. SARS-CoV-2 omicron variant: epidemiological features, biological characteristics, and clinical significance. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.877101.","journal-title":"Front Immunol"},{"key":"1877_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.103737","author":"F Islam","year":"2022","unstructured":"Islam F, Dhawan M, Nafady MH, et al. Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: mutational impacts, concerns, and the possible solutions. Ann Med Surg (Lond). 2022. https:\/\/doi.org\/10.1016\/j.amsu.2022.103737.","journal-title":"Ann Med Surg (Lond)"},{"issue":"18","key":"1877_CR5","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1056\/NEJMc2201607","volume":"386","author":"A Rossler","year":"2022","unstructured":"Rossler A, Knabl L, von Laer D, Kimpel J. Neutralization Profile after recovery from SARS-CoV-2 omicron infection. N Engl J Med. 2022;386(18):1764\u20136. https:\/\/doi.org\/10.1056\/NEJMc2201607.","journal-title":"N Engl J Med"},{"issue":"16","key":"1877_CR6","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMc2201849","volume":"386","author":"J Yu","year":"2022","unstructured":"Yu J, Collier AY, Rowe M, et al. Neutralization of the SARS-CoV-2 omicron BA.1 and BA.2 variants. N Engl J Med. 2022;386(16):1579\u201380. https:\/\/doi.org\/10.1056\/NEJMc2201849.","journal-title":"N Engl J Med"},{"issue":"4","key":"1877_CR7","doi-asserted-by":"publisher","first-page":"612 e611","DOI":"10.1016\/j.cmi.2021.11.010","volume":"28","author":"PY Chia","year":"2022","unstructured":"Chia PY, Ong SWX, Chiew CJ, et al. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study. Clin Microbiol Infect. 2022;28(4):612 e611-612 e617. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.010.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"1877_CR8","doi-asserted-by":"publisher","first-page":"ofac066","DOI":"10.1093\/ofid\/ofac066","volume":"9","author":"CT Bramante","year":"2022","unstructured":"Bramante CT, Proper JL, Boulware DR, et al. Vaccination against SARS-CoV-2 is associated with a lower viral load and likelihood of systemic symptoms. Open Forum Infect Dis. 2022;9(5):ofac066. https:\/\/doi.org\/10.1093\/ofid\/ofac066.","journal-title":"Open Forum Infect Dis"},{"issue":"10321","key":"1877_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(21)02844-0","volume":"399","author":"W Dejnirattisai","year":"2022","unstructured":"Dejnirattisai W, Shaw RH, Supasa P, et al. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Lancet. 2022;399(10321):234\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(21)02844-0.","journal-title":"Lancet"},{"issue":"3","key":"1877_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","volume":"185","author":"M Hoffmann","year":"2022","unstructured":"Hoffmann M, Kruger N, Schulz S, et al. The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic. Cell. 2022;185(3):447-456 e411. https:\/\/doi.org\/10.1016\/j.cell.2021.12.032.","journal-title":"Cell"},{"issue":"7898","key":"1877_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas D, Saunders N, Maes P, et al. Considerable escape of SARS-CoV-2 omicron to antibody neutralization. Nature. 2022;602(7898):671\u20135. https:\/\/doi.org\/10.1038\/s41586-021-04389-z.","journal-title":"Nature"},{"issue":"7","key":"1877_CR12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1056\/NEJMc2119236","volume":"386","author":"A Rossler","year":"2022","unstructured":"Rossler A, Riepler L, Bante D, von Laer D, Kimpel J. SARS-CoV-2 omicron variant neutralization in serum from vaccinated and convalescent persons. N Engl J Med. 2022;386(7):698\u2013700. https:\/\/doi.org\/10.1056\/NEJMc2119236.","journal-title":"N Engl J Med"},{"issue":"6","key":"1877_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/eji.202249841","volume":"52","author":"SR Schulz","year":"2022","unstructured":"Schulz SR, Hoffmann M, Roth E, et al. Augmented neutralization of SARS-CoV-2 omicron variant by boost vaccination and monoclonal antibodies. Eur J Immunol. 2022;52(6):970\u20137. https:\/\/doi.org\/10.1002\/eji.202249841.","journal-title":"Eur J Immunol"},{"issue":"3","key":"1877_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3803\/EnM.2020.719","volume":"35","author":"MC Chang","year":"2020","unstructured":"Chang MC, Hwang JM, Jeon JH, et al. Fasting plasma glucose level independently predicts the mortality of patients with coronavirus disease 2019 infection: a multicenter retrospective cohort study. Endocrinol Metab (Seoul). 2020;35(3):595\u2013601. https:\/\/doi.org\/10.3803\/EnM.2020.719.","journal-title":"Endocrinol Metab (Seoul)."},{"key":"1877_CR15","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1017\/S095026882200022X","volume":"150","author":"H Long","year":"2022","unstructured":"Long H, Li J, Li R, et al. Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19. Epidemiol Infect. 2022;150:e106. https:\/\/doi.org\/10.1017\/S095026882200022X.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"1877_CR16","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1002\/jmv.26608","volume":"93","author":"P Yang","year":"2021","unstructured":"Yang P, Wang N, Wang J, et al. Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19. J Med Virol. 2021;93(4):2168\u201376. https:\/\/doi.org\/10.1002\/jmv.26608.","journal-title":"J Med Virol"},{"key":"1877_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7424748","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Xing H. Influence of fasting plasma glucose level on admission of COVID-19 patients: a retrospective study. J Diabetes Res. 2022. https:\/\/doi.org\/10.1155\/2022\/7424748.","journal-title":"J Diabetes Res"},{"key":"1877_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050776","author":"Z Islam","year":"2022","unstructured":"Islam Z, Yamamoto S, Mizoue T, et al. Association of impaired fasting glucose and diabetes with SARS-CoV-2 spike antibody titers after the BNT162b2 vaccine among health care workers in a tertiary hospital in Japan. Vaccines (Basel). 2022. https:\/\/doi.org\/10.3390\/vaccines10050776.","journal-title":"Vaccines (Basel)"},{"key":"1877_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac288","author":"R Nimri","year":"2022","unstructured":"Nimri R, Marianna R, Yackobovitch-Gavan M, et al. Symptoms and glycemic control in young people with type 1 diabetes following SARS-CoV-2 infection: an observational study. J Clin Endocrinol Metab. 2022. https:\/\/doi.org\/10.1210\/clinem\/dgac288.","journal-title":"J Clin Endocrinol Metab"},{"key":"1877_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12050805","author":"JR Vargas-Rodriguez","year":"2022","unstructured":"Vargas-Rodriguez JR, Valdes Aguayo JJ, Garza-Veloz I, et al. Sustained hyperglycemia and its relationship with the outcome of hospitalized patients with severe COVID-19 potential role of ACE2 upregulation. J Pers Med. 2022. https:\/\/doi.org\/10.3390\/jpm12050805.","journal-title":"J Pers Med"},{"key":"1877_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00567-z","author":"L Tong","year":"2022","unstructured":"Tong L, Xiao X, Li M, et al. A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2. Nat Metab. 2022. https:\/\/doi.org\/10.1038\/s42255-022-00567-z.","journal-title":"Nat Metab"},{"key":"1877_CR22","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn331340-20220325-00065","author":"China NHCotPsRo","year":"2022","unstructured":"China NHCotPsRo. Diagnosis and treatment plan for COVID-19(trial version 9). Int J Epidemiol Infect Dis. 2022. https:\/\/doi.org\/10.3760\/cma.j.cn331340-20220325-00065.","journal-title":"Int J Epidemiol Infect Dis"},{"issue":"10","key":"1877_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3760\/cma.j.issn.0578-1426.2019.10.003","volume":"58","author":"Chinese Diabetes S","year":"2019","unstructured":"Chinese Diabetes S. National Office for Primary Diabetes C. National handbook for the prevention and control of diabetes in primary care. Zhonghua Nei Ke Za Zhi. 2019;58(10):713\u201335. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2019.10.003.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"7906","key":"1877_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","volume":"604","author":"S Iketani","year":"2022","unstructured":"Iketani S, Liu L, Guo Y, et al. Antibody evasion properties of SARS-CoV-2 omicron sublineages. Nature. 2022;604(7906):553\u20136. https:\/\/doi.org\/10.1038\/s41586-022-04594-4.","journal-title":"Nature"},{"issue":"7903","key":"1877_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41586-022-04466-x","volume":"603","author":"K Wang","year":"2022","unstructured":"Wang K, Jia Z, Bao L, et al. Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants. Nature. 2022;603(7903):919\u201325. https:\/\/doi.org\/10.1038\/s41586-022-04466-x.","journal-title":"Nature"},{"key":"1877_CR26","doi-asserted-by":"publisher","DOI":"10.2337\/db22-0053","author":"F D\u2019Addio","year":"2022","unstructured":"D\u2019Addio F, Sabiu G, Usuelli V, et al. Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes. Diabetes. 2022. https:\/\/doi.org\/10.2337\/db22-0053.","journal-title":"Diabetes"},{"key":"1877_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.633767","author":"B Chen","year":"2021","unstructured":"Chen B, Lu C, Gu HQ, et al. Serum uric acid concentrations and risk of adverse outcomes in patients with COVID-19. Front Endocrinol (Lausanne). 2021. https:\/\/doi.org\/10.3389\/fendo.2021.633767.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1877_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12902-021-00745-2","volume":"21","author":"F Hu","year":"2021","unstructured":"Hu F, Guo Y, Lin J, et al. Association of serum uric acid levels with COVID-19 severity. BMC Endocr Disord. 2021;21(1):97. https:\/\/doi.org\/10.1186\/s12902-021-00745-2.","journal-title":"BMC Endocr Disord"},{"key":"1877_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac143","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Gao J, Huang K, et al. SARS-CoV-2 infection causes hyperglycemia in cats. J Infect Dis. 2022. https:\/\/doi.org\/10.1093\/infdis\/jiac143.","journal-title":"J Infect Dis"},{"issue":"1","key":"1877_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-022-01512-w","volume":"21","author":"B Xu","year":"2022","unstructured":"Xu B, Li S, Kang B, Zhou J. The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management. Cardiovasc Diabetol. 2022;21(1):83. https:\/\/doi.org\/10.1186\/s12933-022-01512-w.","journal-title":"Cardiovasc Diabetol"},{"key":"1877_CR31","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.18.2200322","author":"J Bjork","year":"2022","unstructured":"Bjork J, Bonander C, Moghaddassi M, et al. COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants\u2014surveillance results from southern Sweden, December 2021 to March 2022. Euro Surveill. 2022. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.18.2200322.","journal-title":"Euro Surveill"},{"key":"1877_CR32","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.18.2200178","author":"SM Cheng","year":"2022","unstructured":"Cheng SM, Mok CKP, Chan KC, et al. SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022. Euro Surveill. 2022. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.18.2200178.","journal-title":"Euro Surveill"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01877-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-022-01877-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01877-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T08:12:41Z","timestamp":1663056761000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-022-01877-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1877"],"URL":"https:\/\/doi.org\/10.1186\/s12985-022-01877-0","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"assertion":[{"value":"23 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Third People\u2019s Hospital of Changzhou, and was performed in accordance with the 2013 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was exempted for this retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}